Last checked at 28 Sep 2023 10:44
AIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Physiomics Share News (PYC)
PYC Share
Price
PYC Share
News
PYC Share
Chat8
PYC Share
Trades3
PYC
Live RNS
PYC Share
Charts
PYC Level 2
Console
PYC Live
Share Price
PYC Broker
Ratings
PYC Directors
Deals
PYC Financial
Diary
PYC
Fundamentals
PYC Short
Positions
PYC
Media
Physiomics Information
Share Price Information for Physiomics (PYC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1.50
Bid:
1.40
Ask:
1.60
Change:
0.00 (0.00%)
Spread:
0.20 (14.286%)
Open:
1.50
High:
1.50
Low:
1.50
Prev. Close:
1.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.4 Sep 2023 11:21
Physiomics brings in chief operating officer; shares soar
(Alliance News) - Physiomics PLC on Monday named Peter Sargent as its new chief operating officer.
Read more4 Sep 2023 10:27
AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read more31 Aug 2023 16:50
LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation
(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations.
Read more31 Aug 2023 13:51
UPDATE: Physiomics wins new deal following Merck contract extension
(Alliance News) - Physiomics PLC on Thursday said it won its first contract with an unnamed "UK-based biotech client".
Read more31 Aug 2023 10:41
IN BRIEF: Physiomics to extend anti-cancer regimen work with Merck
Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Has been awarded a further contract by existing client Merck KGaA involving pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage and repair agents. Follows on previous Merck-commissioned projects. Expects the contract award to be completed over the next three months.
Read more24 Aug 2023 11:06
ValiRx interim loss widens as costs increase; hails Inaphaea progress
(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio.
Read more8 Aug 2023 15:49
Physiomics inks contract extension with Numab Therapeutics
(Sharecast News) - Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.
Read more8 Aug 2023 10:48
IN BRIEF: Physiomics inks further contract with Numab Therapeutics
Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Says it has been awarded a further contract by its existing client, Numab Therapeutics. Numab Therapeutics is a Switzerland-based biotechnology firm. The project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's clinical programs and follows on from earlier work conducted by Physiomics on the same asset. The project will span two years of the clinical program.
Read more29 Jun 2023 18:55
TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:
Read more27 Jun 2023 10:49
Physiomics completes GBP335,000 fundraise; announces new retail offer
(Alliance News) - Physiomics PLC on Tuesday said it had completed a fundraise, conditional on admission, of GBP335,000 through a placing with Hybridan LLP, and announced a retail offer from Winterflood retail access platform to raise a maximum of GPB150,000.
Read more27 Jun 2023 10:17
AIM WINNERS & LOSERS: Unbound shares drop as calls off sales process
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more31 May 2023 11:57
Physiomics to work with University of Sheffield on cancer research
(Alliance News) - Physiomics PLC on Wednesday said it will collaborate with the University of Sheffield on research into an insect model of cancer treatment.
Read more23 May 2023 12:17
Physiomics shares drop after it cuts full-year guidance
(Alliance News) - Physiomics PLC shares fell on Tuesday, after it lowered its full-year outlook by more than 10%.
Read more23 May 2023 10:32
AIM WINNERS & LOSERS: Physiomics falls as lowers full-year guidance
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more